Neuren reports phase I data on NNZ-2591 and plans to expand development into Prader-Willi syndrome Feb. 16, 2021
AC Immune reports interim data from phase Ib/II study of anti-pTau vaccine candidate ACI-35.030 Feb. 12, 2021
RSS